Pharmaceutical companies GlaxoSmithKline and Merck announced Thursday that they would be manufacturing and distributing their vaccines against cervical cancer in poor nations for under $5 per dose. Although this charitable move makes the vaccine more accessible to the poor on a global scale, it is met with several opinions from how encouraging the vaccine would impact young girls, to the price still not being low enough.
http://bionews-tx.com/news/2013/05/10/cervical-cancer-vaccines-now-less-than-5-per-dose-in-poor-nations/
No comments:
Post a Comment